SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-002881
Filing Date
2024-01-11
Accepted
2024-01-11 12:15:59
Documents
12
Period of Report
2024-01-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDED CURRENT REPORT ea191517-8k_silo.htm   iXBRL 8-K/A 25404
  Complete submission text file 0001213900-24-002881.txt   197849

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE silo-20240109.xsd EX-101.SCH 3021
3 XBRL LABEL FILE silo-20240109_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE silo-20240109_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT ea191517-8k_silo_htm.xml XML 3319
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41512 | Film No.: 24528623
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl
(CF Office: 04 Manufacturing)